Aurinia Pharmaceuticals Inc. (AUPH) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$14.01
Day's range
$14.5

Aurinia Pharmaceuticals Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
TANG CAPITAL MANAGEMENT LLC 02/17/2026 11.33 M $180.71 M   0.00% 8.26%
BLACKROCK, INC. 02/12/2026 7.93 M $126.45 M   6.43% 5.78%
NEA MANAGEMENT COMPANY, LLC 02/17/2026 3.97 M $63.32 M   0.00% 2.89%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 02/13/2026 3.39 M $54.03 M   0.39% 2.47%
STATE STREET CORP 02/13/2026 2.50 M $39.91 M   -7.12% 1.82%
MORGAN STANLEY 02/13/2026 2.22 M $35.36 M   13.88% 1.62%
TWO SIGMA INVESTMENTS, LP 02/17/2026 1.96 M $31.31 M   46.36% 1.43%
RENAISSANCE TECHNOLOGIES LLC 02/12/2026 1.59 M $25.36 M   9.69% 1.16%
MARSHALL WACE, LLP 02/13/2026 1.57 M $25.12 M   6.19% 1.15%
D. E. SHAW & CO., INC. 02/17/2026 1.53 M $24.44 M   68.40% 1.12%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 1.51 M $24.05 M   1.49% 1.10%
VANGUARD GROUP INC 01/29/2026 1.45 M $23.13 M   -6.91% 1.06%
TWO SIGMA ADVISERS, LP 02/17/2026 1.31 M $20.83 M   172.10% 0.95%
KOTLER KEVIN 02/17/2026 1.22 M $19.54 M   100.00% 0.89%
NOMURA HOLDINGS INC 02/17/2026 1.16 M $18.44 M   265.64% 0.84%
JACOBS LEVY EQUITY MANAGEMENT, INC 02/13/2026 1.14 M $18.17 M   -6.58% 0.83%
GOLDMAN SACHS GROUP INC 03/25/2026 1.01 M $16.05 M   19.51% 0.73%
JANE STREET GROUP, LLC 02/12/2026 910.74 K $14.53 M   34.48% 0.66%
JUPITER ASSET MANAGEMENT LTD 02/10/2026 899.48 K $14.35 M   9.22% 0.66%
QUBE RESEARCH & TECHNOLOGIES LTD 02/17/2026 874.35 K $13.95 M   -24.16% 0.64%
MAN GROUP PLC 02/17/2026 852.67 K $13.60 M   368.86% 0.62%
NORTHERN TRUST CORP 02/17/2026 800.14 K $12.76 M   -10.74% 0.58%
CITADEL ADVISORS LLC 02/17/2026 779.50 K $12.43 M   10.94% 0.57%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 02/17/2026 739.44 K $11.79 M   44.26% 0.54%
MILLENNIUM MANAGEMENT LLC 02/17/2026 738.31 K $11.78 M   634.10% 0.54%
JANUS HENDERSON GROUP PLC 02/17/2026 690.63 K $11.02 M   -33.66% 0.50%
TREXQUANT INVESTMENT LP 02/17/2026 682.23 K $10.88 M   -14.84% 0.50%
NUVEEN, LLC 02/12/2026 665.32 K $10.61 M   117.97% 0.49%
LSV ASSET MANAGEMENT 02/06/2026 656.85 K $10.48 M   100.00% 0.48%
BNP PARIBAS ARBITRAGE, SNC 02/10/2026 625.68 K $9.98 M   48.49% 0.46%
DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN 02/17/2026 587.36 K $9.37 M   3.78% 0.43%
RICE HALL JAMES & ASSOCIATES, LLC 02/17/2026 495.64 K $7.91 M   -8.65% 0.36%
AQR CAPITAL MANAGEMENT LLC 02/17/2026 481.34 K $7.68 M   34.34% 0.35%
WOODLINE PARTNERS LP 02/17/2026 456.26 K $7.28 M   0.00% 0.33%
SQUAREPOINT OPS LLC 02/13/2026 444.03 K $7.08 M   -20.10% 0.32%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 432.47 K $6.90 M   -1.25% 0.32%
JANE STREET GROUP, LLC 02/12/2026 409.90 K $6.54 M   4.30% 0.30%
AMERICAN CENTURY COMPANIES INC 02/13/2026 402.93 K $6.43 M   31.06% 0.29%
O'SHAUGHNESSY ASSET MANAGEMENT, LLC 02/11/2026 386.84 K $6.17 M   191.88% 0.28%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 02/10/2026 383.62 K $6.12 M   -29.11% 0.28%
PRUDENTIAL FINANCIAL INC 02/13/2026 372.56 K $5.94 M   281.39% 0.27%
BANK OF AMERICA CORP /DE/ 02/17/2026 367.64 K $5.86 M   -29.49% 0.27%
JPMORGAN CHASE & CO 02/11/2026 337.61 K $5.38 M   -36.69% 0.25%
BANK OF NEW YORK MELLON CORP 02/10/2026 329.35 K $5.25 M   5.06% 0.24%
NORDEA INVESTMENT MANAGEMENT AB 01/08/2026 304.20 K $4.82 M   -15.29% 0.22%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 302.20 K $4.82 M   -26.18% 0.22%
IFP ADVISORS, INC 02/06/2026 274.69 K $4.38 M   4.50% 0.20%
FMR LLC 02/17/2026 268.30 K $4.28 M   22.92% 0.20%
PDT PARTNERS, LLC 02/17/2026 265.49 K $4.23 M   0.00% 0.19%
WELLS FARGO & COMPANY/MN 02/13/2026 264.23 K $4.21 M   257.11% 0.19%

Aurinia Pharmaceuticals Inc institutional Ownership - FAQ's

During the previous two years, 344 institutional investors and hedge funds held shares of Aurinia Pharmaceuticals Inc. The most heavily invested institutionals were:

LSV ASSET MANAGEMENT: 1.04 M

JUPITER ASSET MANAGEMENT LTD: 803,419

BNP PARIBAS ARBITRAGE, SNC: 748,765

Nuveen, LLC: 653,424

JANE STREET GROUP, LLC: 452,104

Connor, Clark & Lunn Investment Management Ltd.: 395,405

52.50% of Aurinia Pharmaceuticals Inc stock is owned by institutional investors.

Institutional investors have bought a total of 89.42 M shares in the last 24 months. This purchase volume represents approximately $1.28 B in transactions.